| Title: | Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration |
|---|
| Authors: | ID Mountzios, Giannis (Author)
ID Remon, J. (Author)
ID Novello, Silvia (Author)
ID Blais, N. (Author)
ID Califano, R. (Author)
ID Čufer, Tanja (Author)
ID Dingemans, Anne-Marie C. (Author)
ID Liu, S. V. (Author)
ID Peled, N. (Author)
ID Pennell, N. A. (Author) |
|---|
| Files: |  PDF - Presentation file, download (106,29 KB)
MD5: 0E9697A221FB531E45F7409FE050F7AE
 URL - Source URL, visit https://academic.oup.com/annonc/article-abstract/30/11/1686/5559466?redirectedFrom=fulltext
|
|---|
| Language: | English |
|---|
| Typology: | 1.03 - Other scientific articles |
|---|
| Organization: |  UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
|
|---|
| Keywords: | non-small cell lung carcinoma, drug therapy, KEYNOTE-024 trial, pemrolizumab, treatment |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Place of publishing: | Velika Britanija |
|---|
| Publisher: | Elsevier |
|---|
| Year of publishing: | 2019 |
|---|
| Number of pages: | str. 1686-1688 |
|---|
| Numbering: | Vol. 30, iss. 11 |
|---|
| PID: | 20.500.12556/DiRROS-12422  |
|---|
| UDC: | 616.2 |
|---|
| ISSN on article: | 1569-8041 |
|---|
| DOI: | 10.1093/annonc/mdz295 |
|---|
| COBISS.SI-ID: | 2048615281 |
|---|
| Copyright: | © 2019 THE AUTHORS |
|---|
| Note: | Nasl. z nasl. zaslona;
Soavtorica iz Slovenije: T. Cufer;
Opis vira z dne 15. 1. 2020;
|
|---|
| Publication date in DiRROS: | 21.09.2020 |
|---|
| Views: | 2402 |
|---|
| Downloads: | 1490 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
